Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 21077789)

1.

Determinants of circulating asymmetric and symmetric dimethylarginines in patients evaluated for acute dyspnea.

Codognotto M, Piccoli A, Rubini C, Cianci V, Vettore G, Mion MM, Artusi C, Plebani M.

Clin Chem Lab Med. 2011 Feb;49(2):237-42. doi: 10.1515/CCLM.2011.032. Epub 2010 Nov 16.

PMID:
21077789
2.

Plasma asymmetric dimethylarginine and cardiovascular events in patients with acute decompensated heart failure.

Dückelmann C, Mittermayer F, Haider DG, Altenberger J, Wolzt M.

Transl Res. 2008 Jul;152(1):24-30. doi: 10.1016/j.trsl.2008.05.001. Epub 2008 Jun 2.

PMID:
18593634
3.

The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.

Anderssohn M, Rosenberg M, Schwedhelm E, Zugck C, Lutz M, Lüneburg N, Frey N, Böger RH.

J Card Fail. 2012 Dec;18(12):904-11. doi: 10.1016/j.cardfail.2012.10.011. Epub 2012 Nov 2.

PMID:
23207078
4.

Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.

Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR, Lainchbury JG, Richards AM, Ordoñez-Llanos J, Santaló M, Pinto YM, Januzzi JL Jr.

Arch Intern Med. 2007 Feb 26;167(4):400-7.

PMID:
17325303
5.

Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure.

Dückelmann C, Mittermayer F, Haider DG, Altenberger J, Eichinger J, Wolzt M.

Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):2037-42. Epub 2007 Jun 14.

6.

Dimethylarginine levels and nutritional status in hemodialysis patients.

Cupisti A, Saba A, D'Alessandro C, Meola M, Panicucci E, Panichi V, Raffaelli A, Barsotti G.

J Nephrol. 2009 Sep-Oct;22(5):623-9.

PMID:
19809995
7.

Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.

Baggish AL, van Kimmenade RR, Januzzi JL Jr.

Am J Cardiol. 2008 Feb 4;101(3A):49-55. doi: 10.1016/j.amjcard.2007.11.020. Review.

PMID:
18243859
8.

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP.

N Engl J Med. 2004 Feb 12;350(7):647-54.

9.

NG, NG-dimethylarginine and NG, NG-dimethylarginine in renal insufficiency.

Al Banchaabouchi M, Marescau B, Possemiers I, D'Hooge R, Levillain O, De Deyn PP.

Pflugers Arch. 2000 Mar;439(5):524-31.

PMID:
10764210
11.

Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema.

Behnes M, Lang S, Breithardt OA, Kaden JJ, Haghi D, Ahmad-Nejad P, Elmas E, Wolpert C, Borggrefe M, Neumaier M, Brueckmann M.

J Heart Valve Dis. 2008 Sep;17(5):557-65.

PMID:
18980090
12.

The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.

van der Burg-de Graauw N, Cobbaert CM, Middelhoff CJ, Bantje TA, van Guldener C.

Eur J Intern Med. 2009 May;20(3):301-6. doi: 10.1016/j.ejim.2008.09.022. Epub 2008 Nov 17.

PMID:
19393498
13.

The L-arginine-asymmetric dimethylarginine ratio is strongly related to the severity of chronic heart failure. No effects of exercise training.

Seljeflot I, Nilsson BB, Westheim AS, Bratseth V, Arnesen H.

J Card Fail. 2011 Feb;17(2):135-42. doi: 10.1016/j.cardfail.2010.09.003. Epub 2010 Oct 28.

PMID:
21300303
14.

Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.

Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL Jr.

J Am Coll Cardiol. 2006 Jan 3;47(1):91-7. Epub 2005 Dec 9.

15.

Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function.

Lüneburg N, von Holten RA, Töpper RF, Schwedhelm E, Maas R, Böger RH.

Clin Sci (Lond). 2012 Feb;122(3):105-11. doi: 10.1042/CS20110013.

PMID:
21777201
16.

[The circulating NTproBNP level, a new biomarker for the diagnosis of heart failure in patients with acute shortness of breath].

Bayés-Genís A.

Rev Esp Cardiol. 2005 Oct;58(10):1142-4. Review. Spanish. No abstract available.

17.

Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis.

Oner-Iyidogan Y, Oner P, Kocak H, Gurdol F, Bekpinar S, Unlucerci Y, Caliskan Y, Cetinalp-Demircan P, Kocak T, Turkmen A.

Clin Exp Med. 2009 Sep;9(3):235-41. doi: 10.1007/s10238-009-0035-3. Epub 2009 Feb 24.

PMID:
19238516
18.

N-terminal pro-brain natriuretic peptide reflects pulmonary capillary leakage in patients with acute dyspnea.

Bayes-Genis A, Bellido-Casado J, Zapico E, Cotes C, Belda J, Lopez L, Santaló M, Ordoñez-Llanos J.

Am J Cardiol. 2004 Sep 1;94(5):669-70.

PMID:
15342307
19.

Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.

Berdagué P, Caffin PY, Barazer I, Vergnes C, Sedighian S, Letrillard S, Pilossof R, Goutorbe F, Piot C, Reny JL.

Am Heart J. 2006 Mar;151(3):690-8.

PMID:
16504634
20.

Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.

Behnes M, Brueckmann M, Ahmad-Nejad P, Lang S, Wolpert C, Elmas E, Kaelsch T, Gruettner J, Weiss C, Borggrefe M, Neumaier M.

Int J Cardiol. 2009 Jun 26;135(2):165-74. doi: 10.1016/j.ijcard.2008.03.045. Epub 2008 Jul 7.

PMID:
18603317
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk